YUNGJIN PHARM. CO. LTD(KR:003520)
₩774.00-37.00 (-4.56%)
KR:003520
YUNGJIN PHARM. CO. LTD financials statements
₩774.00
At close:-37.00 (-4.56%)
Want to see KR:003520 full AI Analyst Report?
YUNGJIN PHARM. CO. LTD (003520) Income Statement
YUNGJIN PHARM. CO. LTD Income Statement
Last quarter (Q2 2026), YUNGJIN PHARM. CO. LTD's total revenue was ₩61.58B, a decrease of 1.50% from the same quarter last year. In Q2, YUNGJIN PHARM. CO. LTD's net income was ₩-2.43B. See YUNGJIN PHARM. CO. LTD’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ₩ 254.26B | ₩ 252.04B | ₩ 234.90B | ₩ 218.38B | ₩ 196.07B | |
| ₩ 75.86B | ₩ 80.35B | ₩ 72.59B | ₩ 64.73B | ₩ 57.94B | |
| ₩ 72.45B | ₩ 71.63B | ₩ 69.47B | ₩ 72.10B | ₩ 71.81B | |
| Depreciation and Amortization | ₩ 8.79B | ₩ 8.71B | ₩ 8.69B | ₩ 7.78B | ₩ 7.38B |
| ₩ 12.20B | ₩ 16.87B | ₩ 7.65B | ₩ -14.30B | ₩ -6.56B | |
| ₩ 3.42B | ₩ 8.72B | ₩ 3.12B | ₩ -7.36B | ₩ -13.88B | |
| ₩ -3.63B | ₩ -5.84B | ₩ -7.04B | ₩ -15.45B | ₩ -266.11M | |
| ₩ -212.00M | ₩ 2.89B | ₩ -3.92B | ₩ -22.81B | ₩ -14.14B | |
| ₩ -227.66M | ₩ 1.23B | ₩ -3.88B | ₩ -21.96B | ₩ -11.58B | |
| Per Share Metrics | |||||
| Basic EPS | ₩ -1.24 | ₩ 6.74 | ₩ -21.19 | ₩ -120.08 | ₩ -63.33 |
| Diluted EPS | ₩ -1.24 | ₩ 6.74 | ₩ -21.19 | ₩ -120.08 | ₩ -63.33 |
| Weighted Average Shares Outstanding | 194.52M | 182.89M | 182.89M | 182.89M | 182.89M |
| Weighted Average Shares Outstanding (Diluted) | 194.52M | 182.89M | 182.89M | 182.89M | 182.89M |
Currency in KRW
